Kathryn Romano insider trades

Open-market stock purchases and sales by Kathryn Romano, Chief Accounting Officer at Krystal Biotech, Inc, from SEC Form 4 filings since Feb 26, 2024.

Recent trades

DateStockTradeValue
Mar 2, 2026KRYS Krystal Biotech, IncSold$201K
Feb 27, 2026KRYS Krystal Biotech, IncSold (not open market)$66.2K
Feb 27, 2026KRYS Krystal Biotech, IncBought (not open market)—
Feb 27, 2026KRYS Krystal Biotech, IncBought (not open market)—
Feb 27, 2026KRYS Krystal Biotech, IncBought (not open market)—
Feb 27, 2026KRYS Krystal Biotech, IncBought (not open market)—
Feb 27, 2026KRYS Krystal Biotech, IncSold (not open market)$899K
Feb 9, 2026KRYS Krystal Biotech, IncSold$541K
Feb 9, 2026KRYS Krystal Biotech, IncSold$1.5M
Feb 9, 2026KRYS Krystal Biotech, IncSold$770K
Feb 9, 2026KRYS Krystal Biotech, IncSold$254K
Feb 9, 2026KRYS Krystal Biotech, IncSold$152K
Feb 9, 2026KRYS Krystal Biotech, IncSold$110K
Feb 9, 2026KRYS Krystal Biotech, IncSold$26.7K
Feb 9, 2026KRYS Krystal Biotech, IncSold (not open market)—
Feb 9, 2026KRYS Krystal Biotech, IncBought (not open market)—

Companies traded

  • KRYS Krystal Biotech, Inc: 32 sales, last Mar 2, 2026

Get free alerts when Kathryn Romano files a new trade →